APA (7th ed.) Citation

Velazquez, C., Orhan, E., Tabet, I., Fenou, L., Orsetti, B., Adélaïde, J., . . . Theillet, C. (2023). BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Frontiers in Oncology, 13, . https://doi.org/10.3389/fonc.2023.1125021

Chicago Style (17th ed.) Citation

Velazquez, Carolina, et al. "BRCA1-methylated Triple Negative Breast Cancers Previously Exposed to Neoadjuvant Chemotherapy Form RAD51 Foci and Respond Poorly to Olaparib." Frontiers in Oncology 13 (2023). https://doi.org/10.3389/fonc.2023.1125021.

MLA (8th ed.) Citation

Velazquez, Carolina, et al. "BRCA1-methylated Triple Negative Breast Cancers Previously Exposed to Neoadjuvant Chemotherapy Form RAD51 Foci and Respond Poorly to Olaparib." Frontiers in Oncology, vol. 13, 2023, https://doi.org/10.3389/fonc.2023.1125021.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.